Venrock Associates V Lp is a venture capital firm that invests in early-stage technology and healthcare companies. Founded in 1969, the firm has a long history of successful investments, including Apple, Intel, and Nest. Venrock has a team of experienced professionals who work closely with their portfolio companies to help them grow and achieve their goals.
Venrock invests in companies that are developing innovative technologies and products. They focus on a variety of sectors, including healthcare, technology, and energy. Venrock's healthcare investments focus on biotechnology, medical devices, and healthcare IT. Their technology investments focus on sectors like software, hardware, and consumer internet. Venrock also invests in companies that are developing new energy technologies.
The Venrock team looks for companies that have a strong management team, a unique product or technology, and a large addressable market. They typically invest between $1 million and $10 million in early-stage companies, and they have the flexibility to participate in later-stage funding rounds as well.
Venrock has a diverse portfolio of companies, including healthcare companies like Castlight Health, a healthcare IT company that provides price transparency tools for consumers, and Illumina, a company that develops gene sequencing technology. In the technology sector, Venrock has invested in companies like AppNexus, a leading advertising technology company, and Nest, a company that developed smart home devices.
Venrock's energy investments include companies like Advanced BioHealing, a company that developed a treatment for diabetic foot ulcers, and Enerkem, a company that develops biofuels from waste materials. These companies are focused on creating sustainable solutions for energy and environmental challenges.
Team and Philosophy
Venrock's team is made up of experienced investors and operators who have a deep understanding of technology and healthcare. The team is led by Bryan Roberts, who has been with Venrock since 1997 and has led investments in companies like Gilead Sciences, Ironwood Pharmaceuticals, and athenahealth.
Venrock's philosophy is based on the belief that the best investment opportunities come from disruptive technologies and products. They believe that innovation can come from anywhere, and they are committed to supporting entrepreneurs who are developing new and innovative solutions to real-world problems.
Venrock Associates V Lp - Net Worth and Insider Trading
Net Worth of Venrock Associates V Lp
As of 2023-03-14, Venrock Associates V Lp's projected worth was at approximately $357 Million. Venrock Associates V Lp is the 10 percent Founder of ZELTIQ Aesthetics Inc. and is the proprietor of approximately 5,458,233 units of ZELTIQ Aesthetics Inc. Venrock Associates V Lp, the 10% Shareholder of Cloudflare Inc., is the holder of approximately 589,294 units of Cloudflare Inc. Venrock Associates V Lp holds around 2,473,187 units of Fate Therapeutics Inc (FATE) stock valued at roughly $13 Million and is a 10% shareholder in Fate Therapeutics Inc. In addition to these, Castlight Health Inc (CSLT) and Anacor Pharmaceuticals Inc (ANAC) are also held by Venrock Associates V Lp. Castlight Health Inc. (CSLT) and Anacor Pharmaceuticals Inc. (ANAC) are the other 2 companies, and their combined weighting in his current holdings is 0.72%.
Trade Tracker for Venrock Associates V Lp Form 4
Venrock Associates V Lp has executed a total of 0 trades in ZELTIQ Aesthetics Inc (ZLTQ) during the last 5 years, based on the most recent SEC Form 4 filings. Among most latest ZELTIQ Aesthetics Inc. transaction involved the sale of 575,000 units on November 14, 2013, for a profit of almost $7 million to Venrock Associates V Lp.
Venrock Associates V Lp has engaged in a total of three trades in Cloudflare Inc (NET) over the last five years, comprising 0 buys and 3 sells, based on the most recent SEC Form 4 filings. The most recent transaction involving Cloudflare Inc. is the deal of 7,000,000 units on July 6, 2020, for a total profit of over $263 Million to Venrock Associates V Lp.
Venrock Associates V Lp has completed a number of 0 trades in Fate Therapeutics Inc (FATE) during the last 5 years, according to SEC Form 4 filings. The most latest transaction involving Fate Therapeutics Inc. was Venrock Associates V Lp purchasing 833,333 units on October 4, 2013, for almost $5 million.
Venrock Associates V Lp is a leading venture capital firm that invests in early-stage technology and healthcare companies. Their portfolio of companies includes some of the most successful and innovative companies in the world, and their team of experienced professionals is committed to helping their portfolio companies achieve their goals. With a focus on disruptive technologies and products, Venrock is well-positioned to continue to be a leading investor in the technology and healthcare sectors.
Spiking Race to 100
We are extremely excited to announce we have a new product called Race to 100. You can track the best investors who have made more than 100% profit in a year and replicate their portfolios in just a few clicks. Be the first to learn these top investors' new trades and trade alongside the shoulders of the giants. Try Race to hundred now at spiking.com/race!
Join the Spiking Wealth Community
Want to learn more about the various trading strategies and see which one suits you the best? Led by Dr. Clemen Chiang, the Spiking Wealth Community is an online community network. Together we are catching the Spikes so that you have faith, hope, and love in everything you do. Spiking Wealth Community helps you to accomplish time squeeze by connecting the dots through online courses, live trading, winning trades, and more. Join us for Free and start your Spiking Wealth Journey today!